Skip to main content
Premium Trial:

Request an Annual Quote

Urban SouthWest Capital LP, DFW Corporate Park, Celera Group, Applera Corp., Illumina, Chesterford (UK) Research Park, RTI Biologics, Progress Corporate Park, HSRL Pathology, Frederick (Md.) Innovative Technology Center Inc., Znomics, Oregon Health and Sc

Grand Prairie, Tex., Office-Warehouse Campus with Life Sciences Space Fetches $14.5M
Urban SouthWest Capital, a limited partnership that owns and manages several Texas commercial properties, has acquired the 22-building, 211,385-square-foot DFW Corporate Park in Grand Prairie, Tex.
The sale price was $14.5 million, according to the website of Wicker and Associates, whose Jon Nylund represented seller Eagle Equity.
Completed in 1981, the 16-acre office park is 85 percent occupied and is located at 2100 North Watson Road (State Highway 360), at its intersection with Carrier Parkway, just north of Interstate 30 near Dallas Fort Worth International Airport. DFW’s single-story buildings include office space, office/warehouse “flex” space, and laboratory space for life sciences tenants.
According to the campus’ web site, suites ranging from 505 square feet to 7,000 square feet were available for lease, at terms from two to five years. Eagle Equity was represented by Jon Nylund of the real estate firm Wicker and Associates.

Celera Eyes New Alameda, Calif., Headquarters After Spinoff from Applera
Celera Group would move its headquarters from Rockville, Md., to Alameda, Calif., upon completing a spinoff of the company from Applera, Applera announced. Applera would keep its offices and 30 employees in Rockville, a spokesman told the Washington Post.
Founded by Craig Venter in 1998, Celera initially sold information from his research that resulted in the mapping of the human genome. When the federal government began offering the data free, Celera evolved into a developer of products that predict risk for several diseases. Venter left the company in 2002 and formed an eponymous institute to continue his genome research.
Celera recorded $43.4 million in revenue last year and two straight profitable quarters, which company spokesman David Speechly told the Post was a key factor in the decision to split the companies, which he termed “a coming of age for Celera,” Adding: “It means that we are growing up."

Illumina Establishes European HQ Within South Cambridge, UK, Science Cluster
Illumina said it will establish a new European headquarters at Chesterford (UK) Research Park, within the South Cambridge science cluster.
The company has agreed to pre-lease the 41,500-square-foot Gonville Laboratory, in an expansion of its presence at the 250-acre tech park dating back to 2006, when it acquired Solexa, which moved in six years earlier. Joint agents Atis Real and Carter Jonas advised the tech park’s owner, a joint venture of Morley Fund Management and The Churchmanor Estates, while the real estate firm Cushman & Wakefield advised Illumina.
Illumina’s lease was the second major tenant secured by Chesterford Park in as many months. In January, Pfizer announced that it would expand its R&D operations there by leasing the new 41,850-square-foot Emmanuel Laboratory and occupying additional temporary space.
To date, more than 215,000 square feet of laboratory and R&D space has been let and occupied or is reaching practical completion. Further phases of construction will extend the development to approximately 600,000 square feet.

Newly Combined Alachua, Fla., Tissue Implant Maker Sheds Space of a Predecessor
RTI Biologics — formed last week through the merger of two Alachua, Fla., companies based at Progress Corporate Park — will vacate the 26,000 square feet of office and manufacturing space leased there by the smaller of the predecessor companies over the course of the year, RTI president Guy Mayer told the Gainesville (Fla.) Sun.
RTI, which says it is the world’s second-largest tissue implant manufacturer behind LifeCell, will move out of the former Tutogen space into the 130,000 square feet in three buildings built by Regeneration Technologies. The combined company has 500 of its 750 employees based at Progress; the rest are scattered at a former Tutogen plant in Germany, a onetime Tutogen sales office in France, and several US marketing and donor recovery sites opened by Regeneration Technologies.
The companies completed their $205 million merger on Feb. 27.

Growing Animal Tissue Firm Multiplies Space Eight-Fold With Move to Thurmont, Md.
HSRL Pathology, a Mount Jackson, Va., company that specializes in microscopic animal tissue evaluation and the creation of pathology reports for business and government clients, is moving its Maryland offices to Thurmont. The 13-employee company made the decision after outgrowing its incubator space just six months after moving into the Frederick (Md.) Innovative Technology Center Inc., also known as FITCI, the News-Post of Frederick reported.
HSRL will move from 1,500 square feet it began occupying last August at FITCI into a 12,000-square-foot former bowling alley and rink it will convert to life sciences use in Thurmont, at 22 Frederick Road. HSRL will build new labs on the first floor and new office space on the second floor of the building, which it has bought from Structural Systems, a supplier of residential building components.
Serge Rousselle, majority owner of HSRL, told the News-Post he hoped to relocate his company’s offices in two months, and its labs in three to four months, adding: “We have applied for a building permit for the lab. We are making no other modification to the building.”

Znomics Expands Lab Space at Oregon Health and Science University
Znomics, a spinout from Oregon Health and Science University specializing in drug discovery based on its library of zebrafish mutations, has expanded its facilities by taking additional laboratory space in the new Biomedical Research Building on the OHSU campus in Portland.
The new roughly 1,600-square-foot lab will increase the company’s facilities by one-third, and will include a laboratory, fish facility, and offices, increasing Znomics' current facilities by one-third. The company expects to occupy the additional space this month.
The new space is near the OHSU laboratories of the company’s president and chief scientific officer, Roger Cone, and scientific advisory board member Thomas Scanlan.

Rochester, Minn., BioBusiness Center in Talks to Fill One More Floor
The BioBusiness Center under construction in Rochester, Minn., is in talks with a prospective tenant business interested in leasing a full floor of the building, now under construction on First Avenue Southwest, the president of Rochester Area Economic Development Inc. told attendees Feb. 27 at the group’s annual luncheon, according to the Post-Bulletin of Rochester.
Gary Smith said the unidentified prospective tenant would join Mayo Clinic Health Solutions, which has signed a lease for five floors of the eight-story, 123,000-square-foot building.
Ground was broken Dec. 11, 2007 for the $26.6 million BioBusiness Center, which is rising near the Mayo Clinic and the Minnesota Partnership for Biotechnology and Medical Genomics.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.